Integrase inhibitor LAT flow devices - EO 14398
Active Purchase Order Awarded Last action
- Contract number
- 75D30126P21238
- Awardee
-
Beacon Scientific Inc. UEI DP2PZHVMDKL4
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $234,000
Award facts
- Opportunity
-
- 75D30126Q79073 Solicitation number
- Contract value 100% obligated
- $234,000.00 Current and potential, with all options
- Completion date 18% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The CDC Pittsburgh issued a purchase order to Beacon Scientific Inc. for $234,000.00 on August 19, 2026, for integrase inhibitor lateral flow devices under Executive Order 14398. Work is performed in San Diego, California. The order carries a firm fixed price and has an ultimate completion date of October 20, 2027.
Quick answers
Who was awarded contract 75D30126P21238?
75D30126P21238 was awarded to Beacon Scientific Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 19, 2026.
How much is contract 75D30126P21238 worth?
The government has obligated $234,000 on 75D30126P21238.
Was contract 75D30126P21238 competed?
The extent of competition for 75D30126P21238 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award